Plain-English translation of NCT07703033 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The ARTILLERY-CarDI study is testing whether measuring calcium deposits in your heart arteries—using scans you're already getting for radiation planning—can help doctors better understand and manage your heart disease risk after breast cancer treatment. Researchers will share your heart risk results with you and your doctors to see if it changes the care you receive and improves your peace of mind.
Breast cancer survivors live longer than ever before, but they face a higher risk of heart disease from cancer treatments like chemotherapy and radiation, as well as lifestyle factors. This study aims to catch heart problems early by using information already available in your routine imaging scans, so doctors can offer personalized prevention strategies tailored to your risk.
You likely qualify if…
You likely don't qualify if…
If you join, your doctors will analyze the CT scan you're already receiving for radiation planning to measure calcium in your heart arteries and estimate your heart disease risk. You and your treating doctor will receive a personalized report with your risk level and recommendations for heart care—which may include lifestyle changes, a visit to a heart specialist, or regular check-ups. Researchers will then track how this information affects your heart care decisions and ask about your satisfaction with the process.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Denmark
Germany
Netherlands
Portugal